Faron Pharmaceuticals Oy (FARN.LSE) Q1 2026 Earnings

4MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-13.63
-11.08
-8.53
-5.98

Details

Expected EPS
-8.808326156240248
Actual EPS
-5.98259790491115
Surprise EPS
2.83
Surprise Percent
+32.08%

Description

Faron Pharmaceuticals Oy (FARN.LSE) has reported earnings of -5.98259790491115 per share for Q1 2026.

0 Comments

Share your thoughts